559. Outcomes of Convalescent Plasma Transfusion for SARS-CoV2 Patients in the Intensive Care Unit

BACKGROUND: SARS-CoV2 is a grave illness and few therapeutic agents have yielded benefit or reduced mortality. Administration of convalescent plasma (CP) in viral illnesses in the past, including SARS, before day 14, has been associated with a shorter hospital course. In the present study, we are in...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalid, Rabeeya, Thomas, Alvin G, Zhu, Daisy, Minga, Iva, Desai, Nirmit, Kaplan, Leonard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776674/
http://dx.doi.org/10.1093/ofid/ofaa439.753

Ejemplares similares

Ejemplares similares